Cargando…
Retinoic acid-loaded PLGA nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancer
Tumour-associated macrophages (TAMs) often promote cancer progression through immunosuppression in the tumour microenvironment (TME). However, the signalling pathways crosstalk responsible for this mechanism remain unclear. The aim of our study was to investigate whether the interaction between TAMs...
Autores principales: | Júnior, Raimundo Fernandes de Araújo, Lira, George A, Schomann, Timo, Cavalcante, Rômulo S, Vilar, Natalia Feitosa, de Paula, Regina Célia Monteiro, Gomes, Raelle Ferreira, Chung, Chih Kit, Jorquera-Cordero, Carla, Vepris, Olena, Chan, Alan B, Cruz, Luis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989692/ https://www.ncbi.nlm.nih.gov/pubmed/36857852 http://dx.doi.org/10.1016/j.tranon.2023.101647 |
Ejemplares similares
-
Optically Coupled PtOEP and DPA Molecules Encapsulated into PLGA-Nanoparticles for Cancer Bioimaging
por: Vepris, Olena, et al.
Publicado: (2022) -
Effect of Oxaliplatin-Loaded Poly (d,l-Lactide-co-Glycolic Acid) (PLGA) Nanoparticles Combined with Retinoic Acid and Cholesterol on Apoptosis, Drug Resistance, and Metastasis Factors of Colorectal Cancer
por: C. de S. L. Oliveira, Ana Luiza, et al.
Publicado: (2020) -
STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer
por: Cavalcante, Rômulo S., et al.
Publicado: (2021) -
Nanocarriers as a Tool for the Treatment of Colorectal Cancer
por: C. de S. L. Oliveira, Ana Luiza, et al.
Publicado: (2021) -
Evaluation of the Antitumour and Antiproliferative Effect of Xanthohumol-Loaded PLGA Nanoparticles on Melanoma
por: Fonseca, Magda, et al.
Publicado: (2021)